LEADER 05459nam 2201441z- 450 001 9910557432803321 005 20231214132842.0 035 $a(CKB)5400000000043395 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68346 035 $a(EXLCZ)995400000000043395 100 $a20202105d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aMetabolic Syndrome$eFrom Etiology to Prevention and Clinical Management 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 electronic resource (348 p.) 311 $a3-03943-989-8 311 $a3-03943-990-1 330 $aMetabolic syndrome has been the topic of countless publications. It still remains a subject of debate and some experts have even questioned its clinical relevance. Its diagnosis is nevertheless predictive of an increased risk of type 2 diabetes and cardiovascular disease even in the absence of traditional risk factors. Many years ago, our team made the point that the most prevalent form of metabolic syndrome was linked to abdominal obesity, which can be found even among individuals who are not considered obese by body weight standards. Imaging techniques such as computed tomography and magnetic resonance imaging have revealed the link between regional body fat partitioning and cardiometabolic risk. Visceral obesity is the most dangerous form of obesity, with subcutaneous obesity being associated with lower health risk. We have proposed that excess visceral fat may be a marker of subcutaneous adipose tissue dysfunction not being able to serve as a metabolic sink, causing lipid accumulation at undesired sites, a condition described as ectopic fat deposition. Among the effective approaches to prevent, delay, or manage metabolic syndrome, lifestyle changes are the key elements, with an emphasis on the importance of healthy global dietary patterns, regular physical activity, and adequate sleep quality. 517 $aMetabolic Syndrome 606 $aHumanities$2bicssc 606 $aSocial interaction$2bicssc 610 $atrimethylamine N-oxide (TMAO) 610 $aobesity 610 $avisceral adiposity index (VAI) 610 $afatty liver index (FLI) 610 $ametabolic syndrome (MetS) 610 $ahealthy lifestyle score 610 $ametabolic syndrome 610 $aSUN cohort 610 $abranched-chain amino acids 610 $aacylcarnitines 610 $adietary protein sources 610 $ameat 610 $ametabolite profiling 610 $adiet 610 $apediatric obesity 610 $anonalcoholic fatty liver disease 610 $asaliva 610 $ametabolomics 610 $agas-chromatography mass spectrometry 610 $aanthropometric indexes 610 $adiagnosis criteria 610 $aadolescents 610 $abone mineral density 610 $ainsulin resistance 610 $abone health 610 $aosteoporosis 610 $aatherosclerotic cardiovascular disease 610 $avisceral fat accumulation 610 $auniversal public health screening program 610 $ahealth check-up 610 $ahealth guidance 610 $acity planning 610 $acarbohydrate 610 $apolyunsaturated fat 610 $amonounsaturated fat 610 $asaturated fat 610 $afish oil 610 $ameta-analyses 610 $alipids 610 $aglucose 610 $ablood pressure 610 $abreastfeeding duration 610 $abirth weight 610 $acardiorespiratory fitness 610 $acardiovascular disease 610 $aexercise training 610 $alinseed 610 $asecoisolariciresinol diglucoside 610 $ahigh-carbohydrate 610 $ahigh-fat diet 610 $aanthropometric indices 610 $acardiometabolic risk 610 $aelderly 610 $arisk 610 $apediatric 610 $aadolescent 610 $asugar-sweetened beverages 610 $aweight gain 610 $atype 2 diabetes 610 $aolder adults 610 $amacronutrient intake 610 $adietary intake 610 $afat intake 610 $aendocannabinoids 610 $aendocannabinoidome 610 $amicrobiome 610 $afructose 610 $ahypertriglyceridemia 610 $ametabolism 610 $asleep 610 $asleep apnea 610 $asleep habit 610 $asleep duration 610 $achronotype 610 $asocial jetlag 610 $aethnicity 610 $aprevention 610 $alifestyle 610 $acardiometabolic 610 $aexercise 610 $aabdominal obesity 610 $aenergy balance 610 $acaloric restriction 610 $anon-alcoholic fatty liver disease 610 $aphysical activity 610 $asaturated fatty acids 610 $adiet quality 610 $adietary guidelines 615 7$aHumanities 615 7$aSocial interaction 700 $aLemieux$b Isabelle$4edt$01302075 702 $aDespre?s$b Jean-Pierre$4edt 702 $aLemieux$b Isabelle$4oth 702 $aDespre?s$b Jean-Pierre$4oth 906 $aBOOK 912 $a9910557432803321 996 $aMetabolic Syndrome$93026101 997 $aUNINA